Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.08

-2.9%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (1369)	8/2/2000 9:27:30 PM
From: Spekulatius	Read Replies (1) of 52153

Valuation is always relative. When looking at a stock as an investment, I try to evaluate how a company is valued against its peers and how I anticipate the peer group to do in the future. In the case of GZMO, we are looking at a company with a market cap of a bit more than 120M$, top notch technology platform(s) with its peers having market caps in the B$ range. Of course GZMO could go to 4$ but overall, I believe that at it current valuation, GZMO is a good speculation and that's why I am buying. In addition, its important to look at the near term news flux. I expect the news flux for GZMO to be positive, which increases the chance of a stock price increase even in a rough market.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next